Platelet-leukocyte aggregation induced by PAR agonists: Regulation by nitric oxide and matrix metalloproteinases

British Journal of Pharmacology

Volumn 143, Issue 7, 2004, Pages 845-855

  Chung, Ada W Y ^a   Radomski, Anna ^b   Alonso Escolano, David ^b   Jurasz, Paul ^b   Stewart, Michael W ^c   Malinski, Tadeusz ^d   Radomski, Marek W ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c ViReXX Research   (Canada)

^d OHIO UNIVERSITY   (United States)

Author keywords

Matrix metalloproteinases; Nitric oxide; Platelet leukocyte aggregation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLSALICYLIC ACID; APYRASE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEPTIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR ACTIVATING PEPTIDE; PROTEINASE ACTIVATED RECEPTOR AGONIST; S NITROSOGLUTATHIONE; STROMELYSIN; THROMBIN; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SUBSTRATE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LEUKOCYTE; LEUKOCYTE AGGREGATION; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL AGGREGATION; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MATRIX METALLOPROTEINASES; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; NITRIC OXIDE; PLATELET AGGREGATION; PORPHYRINS; THROMBIN;

EID: 10844286331     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705997     Document Type: Article

References (72)

1. ALBERT, J., RADOMSKI, A., SOOP, A., SOLLEVI, A., FROSTELL, C. & RADOMSKI, M.W. (2003). Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol. Scand., 47, 407-410.
2. ALONSO-ESCOLANO, D., STRONGIN, A.Y., CHUNG, A.W., DERYUGINA, E.I. & RADOMSKI, M.W. (2004). Membrane type-I matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br. J. Pharmacol., 141, 241-252.
3. APPELDOORN, C.C.M., MOLENAAR, T.J.M., BONNEFOY, A., VAN LEEUVEN, S.H., VANDERVOORT, P.A.H., HOYLAERTS, M.F., VAN BERKEL, T.J.C. & BIESSEN, E.A.L. (2003). Rational optimization of a short human p-selectin-binding peptide leads to nanomolar affinity antagonists. J. Biol. Chem., 278, 10201-10207.
4. BAR-OR, A., NUTTALL, R.K., DUDDY, M., ALTER, A., KIM, H.J., IFERGAN, I., PENNlNGTON, C.J., BOURGOIN, P., EDWARDS, D.R. & YONG, V.W. (2003). Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain, 126, 2738-2749.
5. BERGEMEIER, W., BURGER, P.C., PIFFATH, C.L., HOFFMEIESTER, K.M., HARTWIG, J.H., NIESWANDT, B. & WAGNER, D.D. (2003). Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood, 102, 4229-4235.
6. BORREGAARD, N. & COWLAND, J.B. (1997). Granules of the human neutrophilic polymorphonuclear leukocyte. Blood, 89, 3503-3521.
7. CEDRO, K., RADOMSKI, A., RADOMSKI, M.W., RUZYLLO, W. & HERBACZYNSKA-CEDRO, K. (2003). Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina: a preliminary study. Int. J. Cardiol., 92, 177-180.
8. CHUNG, A.W., JURASZ, P., HOLLENBERG, M.D. & RADOMSKI, M.W. (2002). Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br. J. Pharmacol., 135, 1123-1132.
9. DEL-MASCHIO, A., EVANGELISTA, V., RAJTAR, G., CHEN, Z.M., CERLETTI, C. & DE-GAETANO, G. (1990). Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am. J. Physiol., 258, H870-H879.
10. DERYUGINA, E.I., RATNIKOV, B., MONOSOV, E., POSTNOVA, T.I., DISCIPIO, R., SMITH, J.W. & STRONGIN, A.Y. (2001). MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res., 263, 209-223.
11. DERYUGINA, E.I., RATNIKOV, B.I., POSTNOVA, T.I., ROZANOV, D.V. & STRONGIN, A.Y. (2002). Processing of integrin alpha(v) subunit by membrane type I matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem., 277, 9749-9756.
12. DIACOVO, T.G., ROTH, S.J., BUCCOLA, J.M., BAINTON, D.F. & SPRINGER, T.A. (1996). Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood, 88, 146-157.
13. FERNANDEZ-PATRON, C., MARTINEZ-CUESTA, M.A., SALAS, E., SAWICKI, G., WOZNIAK, M., RADOMSKI, M.W. & DAVIDGE, S.T. (1999a). Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb. Haemostasia, 82, 1730-1735.
14. FERNANDEZ-PATRON, C., RADOMSKI, M.W. & DAVIDGE, S.T. (1999b). Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ. Res. (Online), 85, 906-911.
15. FORLOW, S.B., MCEVER, R.P. & NOLLERT, M.U. (2000). Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood, 95, 1317-1323.
16. FREEDMAN, J.E. & KEANEY, J.F. (1999). Nitric oxide and superoxide detection in human platelets. Methods Enzymol., 301, 61-70.
17. GAHMBERG, C.G., VALMU, L., FAGERHOLM, S., KOTOVUORI, P., IHANUS, E., TIAN, L. & PESSA-MORIKAWA, T. (1998). Leukocyte integrins and inflammation. Cell. Mol. Life Sci.: Cmls, 54, 549-555.
18. GALT, S.W., LINDEMANN, S., ALLEN, L., MEDD, D.J., FALK, J.M., MCINTYRE, T.M., PRESCOTT, S.M., KRAISS, L.W., ZIMMERMAN, O.A. & WEYRICH, A.S. (2002). Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ. Res. (Online), 90, 1093-1099.
19. GARTHWAITE, J., SOUTHAM, E., BOULTON, C.L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184-188.
20. GRANGER, D.N. & KUBES, P. (1994). The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J. Leukocyte Biol. 55, 662-675.
21. HUO, Y., SCHOBER, A., FORLOW, S.B., SMITH, D.F., HYMAN, M.C., JUNG, S., LITTMAN, D.R., WEBER, C. & LEY, K. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med., 9, 61-67.
22. JAYACHANDRAN, M., OWEN, W.G. & MILLER, V.M. (2003). Effects of ovariectomy on aggregation, secretion, and metalloproteinases in porcine platelets. Am. J. Physiol. Heart Circ. Physiol., 284, H1679-H1685.
23. JURASZ, P., CHUNG, A.W., RADOMSKI, A. & RADOMSKI, M.W. (2002). Nonremodeling properties of matrix metalloproteinases: the platelet connection. Circ. Res. (Online), 90, 1041-1043.
24. JURASZ, P., SAWICKI, G., DUSZYK, M., SAWICKA, J., MIRANDA, C., MAYERS, I. & RADOMSKI, M.W. (2001). Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res., 61, 376-382.
25. KAHN, M.L., NAKANISHI-MATSUI, M., SHAPIRO, M.J., ISHIHARA, H. & COUGHLIN, S.R. (1999). Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest., 103, 879-887.
26. KAZES, I., ELALAMY, I., SRAER, J.D., HATMI, M. & NGUYEN, G. (2000). Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood, 96, 3064-3069.
27. KLINGER, M.H. & JELKMANN, W. (2002). Role of blood platelets in infection and inflammation. J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res., 22, 913-922.
28. KONSTANTOPOULOS, K., NEELAMEGHAM, S., BURNS, A.R., HENTZEN, E., KANSAS, G.S., SNAPP, K.R., BERG, E.L., HELLUMS, J.D., SMITH, C.W., MCINTIRE, L.V. & SIMON, S.I. (1998). Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin. Circulation, 98, 873-882.
29. KUIJPER, P.H., GALLARDO-TORES, H.I., LAMMERS, J.W., SIXMA, J.J., KOENDERMAN, L. & ZWAGINGA, J.J. (1998). Platelet associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions. Thromb. Haemostaais, 80, 443-448.
30. KUIJPER, P.H., GALLARDO TORRES, H.I., VAN DER LINDEN, J.A., LAMMERS, J.W., SIXMA. J.J., KOENDERMAN, L. & ZWAGINGA, J.J. (1996). Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood, 87, 3271-3281.
31. LARSEN, E., CELI, A., GILBERT, G.E., FURIE, B.C., ERBAN, J.K., BONFANTI, R., WAGNER, D.D. & FURIE, B. (1989). PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell, 59, 305-312.
32. LAU, L.F., PUMIGLIA, K., COTE, Y.P. & FEINSTEIN, M.B. (1994). Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem. J., 303 (Part 2), 391-400.
33. LAUER-FIELDS, J.L., TUZINSKI, K.A., SHIMOKAWA, K., NAGASE, H. & FIELDS, G.B. (2000). Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases. J. Biol. Chem., 275, 13282-13290.
34. MACFARLANE, S.R., SEATTER, M.J., KANKE, T., HUNTER, G.D. & PLEVIN, R. (2001). Proteinase-activated receptors. Pharmacol. Rev., 53, 245-282.
35. MALINSKI, T. & CZUCHAJOWSKI, L. (1996). Measurements by electrochemical methods. In: Methods of Nitric Oxide Research, ed. Feelisch, M. & Stamler, J.S. pp. 319-339. New York: John Wiley & Sons Inc.
36. MALINSKI, T. & TAHA, Z. (1992). Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature, 358, 676-678.
37. MALINSKI, T., RADOMSKI, M.W., TAHA, Z. & MONCADA, S. (1993). Direct electrochemical measurement of nitric oxide released from human platelets. Biochem. Biophys. Res. Commun., 194, 960-965.
38. MARCET-PALACIOS, M., GRAHAM, K., CASS, C., BEFUS, A.D., MAYERS, I. & RADOMSKI, M.W. (2003). Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J. Pharmacol. Exp. Ther., 307, 429-436.
39. MARTINEZ-CUESTA, M.A., SALAS, E., RADOMSKI, A. & RADOMSKI, M.W. (2001). Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Med. Sci. Monitor, 7, 646-651.
40. MAYERS, I., HURST, T., PUTTAGUNTA, L., RADOMSKI, A., MYCYK, T., SAWICKI, G., JOHNSON, D. & RADOMSKI, M.W. (2001). Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J. Thorac. Cardiovasc. Surg., 122, 746-752.
41. MAYERS, I., HURST, T., RADOMSKI, A., JOHNSON, D., FRICKER, S., BRIDGER, G., CAMERON, B., DARKES, M. & RADOMSKI, M.W. (2003). Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. J. Thorac. Cardiovas. Surg., 125, 661-668.
42. MCCALL, T.B., BOUGHTON-SMITH, N.K., PALMER, R.M., WHITTLE, B.J. & MONCADA, S. (1989). Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem. J., 261, 293-296.
43. MCQUIBBAN, G.A., GONG, J.H., TAM, E.M., MCCULLOCH, C.A., CLARK-LEWIS, I. & OVERALL, C.M. (2000a). Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science, 289, 1202-1206.
44. MCQUlBBAN, G.A., GONG, J.H., TAM, E.M., MCCULLOCH, C.A., CLARK-LEWIS, I. & OVERALL, C.M. (2000b). Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science, 289, 1202-1206.
45. MERTEN, M., PAKALA, R., THIAGARAJAN, P. & BENEDICT, C.R. (1999). Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation, 99, 2577-2582.
46. MOORE, K.L. (1998). Structure and function of P-selectin glycoprotein ligand-1. Leuk. Lymphoma, 29, 1-15.
47. MORO, M.A., RUSSEL, R.J., CELLEK, S., LIZASOAlN, I., SU, Y., DARLEY-USMAR, V.M., RADOMSKI, M.W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
48. NAGATA, K., TSUJI, T., TODOROKI, N., KATAGIRI, Y., TANOUE, K., YAMAZAKI, H., HANAI, N. & IRIMURA, T. (1993). Activated platelets induce Superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J. Immunol. (Baltimore, MD: 1950), 151, 3267-3273.
49. OPDENAKKER, G., VAN-DEN-STEEN, P.E., DUBOIS, B., NELISSEN, L, VAN-COILLIE, E., MASURE, S., PROOST, P. & VAN-DAMME, J. (2001). Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukocyte Biol., 69, 851-859.
50. PASQUET, J.M., TOTI, F., NURDEN, A.T. & DACHARY-PRIGENT, J. (1996). Procoagulant activity and active calpain in platelet-derived microparticles. Thromb. Res., 82, 509-522.
51. PEI, D. (1999). Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res., 9, 291-303.
52. RADOMSKI, A., JURASZ, P., SANDERS, E.J., OVERALL, C.M., BIGG, H.F., EDWARDS, D.R. & RADOMSKI, M.W. (2002). Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br. J. Pharmacol., 137, 1330-1338.
53. RADOMSKI, A., SAWICKI, G., OLSON, D.M. & RADOMSKI, M.W. (1998). The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br. J. Pharmacol., 125, 1455-1462.
54. RADOMSKI, A., STEWART, M.W., JURASZ, P. & RADOMSKI, M.W. (2001). Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Br. J. Pharmacol., 134, 1013-1020.
55. RADOMSKI, M. & MONCADA, S. (1983). An improved method for washing of human platelets with prostacyclin. Thromb. Res., 30, 383-389.
56. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1987a). The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639-646.
57. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1987b). Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol., 92, 181-187.
58. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1990a). Characterization of the L-arginine:nitric oxide pathway in human platelets. Br. J. Pharmacol., 101, 325-328.
59. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1990b). An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U.S.A., 87, 5193-5197.
60. RADOMSKI, M.W., REES, D.D., DUTRA, A. & MONCADA, S. (1992). S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol., 107, 745-749.
61. SANTOSO, S., SACHS, U.J., KROLL, H., LINDER, M., RUF, A., PREISSNER, K.T. & CHAVAKIS, T. (2002). The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-I. J. Exp. Med., 196, 679-691.
62. SAWICKI, G., RADOMSKI, M.W., WINKLER-LOWEN, B., KRZYMIEN, A. & GUILBERT, L.J. (2000). Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol. Reprod., 63, 1390-1395.
63. SAWICKI, G., SALAS, E., MURAT, J., MISZTA-LANE, H. & RADOMSKI, M.W. (1997). Release of gelatinase A during platelet activation mediates aggregation. Nature, 386, 616-619.
64. SAWICKI, G., SANDERS, E.J., SALAS, E., WOZNIAK, M., RODRIGO, J. & RADOMSKI, M.W. (1998). Localization and translocation of MMP-2 during aggregation of human platelets. Thromb. Haemostasis, 80, 836-839.
65. SIMON, D.I., CHEN, Z., XU, H., LI, C.Q., DONG, J., MCINTIRE, L.V., BALLANTYNE, C.M., ZHANG, L., FURMAN, M.I., BERNDT, M.C. & LOPEZ, I.A. (2000). Platelet glycoprotein ibalpha is a counter-receptor for the leukocyte integrin Mac-1 (CDIIb/CD18). J. Exp. Med., 192, 193-204.
66. STRICKER, T.P., DUMIN, I.A., DICKESON, S.K., CHUNG, L., NAGASE, H., PARKS, W.C. & SANTORO, S.A. (2001). Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J. Biol. Chem., 276, 29375-29381.
67. UPADHYA, G.A. & STRASBERG, S.M. (2002). Platelet adherence to isolated rat hepatic sinusoidal endothelial cells after cold preservation. Transplantation, 73, 1764-1770.
68. VAN DEN STEEN, P.E., PROOST, P., WUYTS, A., VAN DAMME, J. & OPDENAKKER, G. (2000). Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood, 96, 2673-2681.
69. VAN DEN STEEN, P.E., WUYTS, A., HUSSON, S.J., PROOST, P., VAN DAMME, J. & OPDENAKKER, G. (2003). Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem., 270, 3739-3749.
70. VASSALLO, R.R., KIEBER-EMMONS, T., CICHOWSKI, K. & BRASS, L.F. (1992). Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J. Biol. Chem., 267, 6081-6085.
71. WEBER, C. & SPRINGER, T.A. (1997). Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J. Clin. Invest., 100, 2085-2093.
72. WOESSNER JR, J.F. (1999). Matrix metalloproteinase inhibition: from the Jurassic to the Third Millennium. Ann. NY Acad. Sci., 878, 388-403.